Foundation for Innovative New Diagnostics Find

Analysis

Foundation for Innovative New Diagnostics Find is a registered charity in United States, based in Switzerland. It received its IRS tax-exemption ruling in October 2003, 23 years ago. Its declared purposes cover medical research, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Foundation for Innovative New Diagnostics Find reported income of $90.6m and spending of $96.1m, spending 106% of what it took in. Across the 5 years on record, from December 2019 to December 2023, income grew from $56.7m to $90.6m (+60%), an average of +12% a year. The sharpest change came in the year to December 2020, when income rose by 73%. Over the whole period it spent 97% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Foundation for Innovative New Diagnostics Find sits at the 95th percentile: it is larger than about 95% of them. Against every charity in United States with reported income it ranks in the 99th percentile. Charities of a similar size with the same main cause include Wake Forest Emergency Providers ($90.5m), Southwest Transplant Alliance Inc ($90.7m) and Dap Health Inc ($90.4m).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 96% of the total. Compensation of current officers, directors and key employees was $2.4m (2.5% of expenses). Other salaries and wages came to $26.4m. At year end it held assets of $81.4m against liabilities of $65.3m, net assets of $16.2m. It reported 147 employees.